Cargando…

Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels

BACKGROUND: Our previous work revealed that rhomboid domain-containing protein 1 (RHBDD1) participates in the modulation of cell growth and apoptosis in colorectal cancer cells. This study aimed to investigate the function of RHBDD1 in regulating breast cancer progression and its underlying molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Zhao, Yuechao, Wang, Changjun, Ju, Hongge, Liu, Wenjie, Zhang, Xiaohui, Miao, Shiying, Wang, Linfang, Sun, Qiang, Song, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172813/
https://www.ncbi.nlm.nih.gov/pubmed/30286765
http://dx.doi.org/10.1186/s12964-018-0267-5
_version_ 1783361015779426304
author Zhang, Xin
Zhao, Yuechao
Wang, Changjun
Ju, Hongge
Liu, Wenjie
Zhang, Xiaohui
Miao, Shiying
Wang, Linfang
Sun, Qiang
Song, Wei
author_facet Zhang, Xin
Zhao, Yuechao
Wang, Changjun
Ju, Hongge
Liu, Wenjie
Zhang, Xiaohui
Miao, Shiying
Wang, Linfang
Sun, Qiang
Song, Wei
author_sort Zhang, Xin
collection PubMed
description BACKGROUND: Our previous work revealed that rhomboid domain-containing protein 1 (RHBDD1) participates in the modulation of cell growth and apoptosis in colorectal cancer cells. This study aimed to investigate the function of RHBDD1 in regulating breast cancer progression and its underlying molecular basis. METHODS: Immunohistochemistry was performed to evaluate RHBDD1 expression in 116 breast cancer tissue and 39 adjacent normal tissue and expression of RHBDD1, phospho-Akt (p-Akt) and cyclin-dependent kinase 2 (CDK2) in the same 84 breast cancer specimens. RHBDD1-knock-out cells were established using breast cancer cell lines. In vitro studies were carried out to estimate the function of RHBDD1 in cell proliferation, migration and invasion. Fluorescence microscopy assay and flow cytometric analysis were used to measure apoptosis and cell cycle regulation. RNA sequencing and western blot analysis were used to investigate the molecular mechanisms of RHBDD1. RESULTS: RHBDD1 was highly up-regulated in breast cancer tissue compared with that in normal tissue and associated with pathological tumor (pT) stage, pathological tumor-node-metastasis (pTNM) stage and estrogen receptor (ER) expression. RHBDD1 up-regulation was associated with poor prognosis in several subtypes of breast cancer. Deletion of RHBDD1 promoted apoptosis and suppressed proliferation, migration and invasion in breast cancer cells. RHBDD1 deletion suppressed Akt activation and decreased CDK2 protein level via proteasome pathway, thus inhibited cell cycle progression and G1/S phase transition. Moreover, the protein level of RHBDD1, p-Akt and CDK2 was significantly positively correlated in breast cancer tissue. CONCLUSIONS: Our study reveals that RHBDD1 promotes breast cancer progression by regulating p-Akt and CDK2 protein levels, and might be a potential biomarker and prognostic indicator for breast cancer patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0267-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6172813
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61728132018-10-15 Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels Zhang, Xin Zhao, Yuechao Wang, Changjun Ju, Hongge Liu, Wenjie Zhang, Xiaohui Miao, Shiying Wang, Linfang Sun, Qiang Song, Wei Cell Commun Signal Research BACKGROUND: Our previous work revealed that rhomboid domain-containing protein 1 (RHBDD1) participates in the modulation of cell growth and apoptosis in colorectal cancer cells. This study aimed to investigate the function of RHBDD1 in regulating breast cancer progression and its underlying molecular basis. METHODS: Immunohistochemistry was performed to evaluate RHBDD1 expression in 116 breast cancer tissue and 39 adjacent normal tissue and expression of RHBDD1, phospho-Akt (p-Akt) and cyclin-dependent kinase 2 (CDK2) in the same 84 breast cancer specimens. RHBDD1-knock-out cells were established using breast cancer cell lines. In vitro studies were carried out to estimate the function of RHBDD1 in cell proliferation, migration and invasion. Fluorescence microscopy assay and flow cytometric analysis were used to measure apoptosis and cell cycle regulation. RNA sequencing and western blot analysis were used to investigate the molecular mechanisms of RHBDD1. RESULTS: RHBDD1 was highly up-regulated in breast cancer tissue compared with that in normal tissue and associated with pathological tumor (pT) stage, pathological tumor-node-metastasis (pTNM) stage and estrogen receptor (ER) expression. RHBDD1 up-regulation was associated with poor prognosis in several subtypes of breast cancer. Deletion of RHBDD1 promoted apoptosis and suppressed proliferation, migration and invasion in breast cancer cells. RHBDD1 deletion suppressed Akt activation and decreased CDK2 protein level via proteasome pathway, thus inhibited cell cycle progression and G1/S phase transition. Moreover, the protein level of RHBDD1, p-Akt and CDK2 was significantly positively correlated in breast cancer tissue. CONCLUSIONS: Our study reveals that RHBDD1 promotes breast cancer progression by regulating p-Akt and CDK2 protein levels, and might be a potential biomarker and prognostic indicator for breast cancer patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0267-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-04 /pmc/articles/PMC6172813/ /pubmed/30286765 http://dx.doi.org/10.1186/s12964-018-0267-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Xin
Zhao, Yuechao
Wang, Changjun
Ju, Hongge
Liu, Wenjie
Zhang, Xiaohui
Miao, Shiying
Wang, Linfang
Sun, Qiang
Song, Wei
Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title_full Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title_fullStr Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title_full_unstemmed Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title_short Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels
title_sort rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-akt and cdk2 levels
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172813/
https://www.ncbi.nlm.nih.gov/pubmed/30286765
http://dx.doi.org/10.1186/s12964-018-0267-5
work_keys_str_mv AT zhangxin rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT zhaoyuechao rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT wangchangjun rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT juhongge rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT liuwenjie rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT zhangxiaohui rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT miaoshiying rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT wanglinfang rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT sunqiang rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels
AT songwei rhomboiddomaincontainingprotein1promotesbreastcancerprogressionbyregulatingthepaktandcdk2levels